12 cases of brain disease after vaccines

Oct 24, 2006

The U.S. Food and Drug Administration said 12 cases of a neurological disorder have been reported following the application of a meningococcal vaccine.

The FDA said the 12 cases of Guillain-Barre Syndrome have been reported after administering of the vaccines, which are manufactured by French company Sanofi Pasteur, since October 2005, The Wall Street Journal reported Tuesday.

However, the FDA said sufficient evidence was not available to tie the vaccine to the disease and patients should continue to use it if instructed by their doctors.

The vaccines are used to prevent meningococcal disease, which causes bacterial meningitis -- an infection that attacks the lining of the brain and spinal cord. The disease affects about 1-in-100,000 young people every year.

Copyright 2006 by United Press International

Explore further: Community service programs that include reflection found to be more beneficial to youth

add to favorites email to friend print save as pdf

Related Stories

New material puts a twist in light

1 hour ago

Scientists at The Australian National University (ANU) have uncovered the secret to twisting light at will. It is the latest step in the development of photonics, the faster, more compact and less carbon-hungry ...

Controversial Alaska mine project wins one in Congress

2 hours ago

Supporters of the embattled Pebble Mine project in Alaska are making a desperate effort in Congress and the courts to keep it alive in the face of warnings from the Environmental Protection Agency that it could devastate ...

Recommended for you

User comments : 0